Related Experiment Video
Updated: Aug 3, 2026

Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices
Published on: May 9, 2018
Mega-experiments to identify and assess diffuse carcinogenic risks
M Soffritti1, F Belpoggi, F Minardi
1European Ramazzini Foundation for Oncology and Environmental Sciences, Bologna, Italy. crcfr@tin.it
Abstract:
Diffuse carcinogenic risks, that is, those of low potency involving large areas of population and sometimes all mankind, pose a serious public health problem. Controlling these risks might help to reduce the incidence of, and mortality from, cancer. Because of their low expected carcinogenic potential, these risks are difficult to expose or assess. Epidemiologic investigation is of limited use in this field and yields its data too late to be useful. Experimental studies offer the only possible approach for assessing such risks. To increase experimental sensitivity and consistency of results, mega-experiments must be designed. That is, experiments that use a large number of animals with a well-known basic tumorigram, that extend the exposure and the biophase for as long as possible, that carefully observe the effects, and that are performed with suitable standardized methods. In the last 15 years the Ramazzini Foundation, in its Cancer Research Center at Bentivoglio, has conducted or planned five mega-experiments. Initial results indicate the great potential of these methods for identifying and assessing diffuse risks.
Insights
Identifying diffuse carcinogenic risks, which affect large populations, is crucial for public health. Large-scale "mega-experiments" show promise in assessing these low-potency risks and reducing cancer incidence.
Area of Science:
- Toxicology
- Public Health
- Cancer Research
Background:
- Diffuse carcinogenic risks pose a significant public health challenge due to their low potency and widespread impact.
- Assessing these risks is difficult using traditional epidemiological methods, which are often slow and limited in scope.
- Experimental studies are essential for evaluating diffuse carcinogenic risks, but require enhanced sensitivity and consistency.
Purpose of the Study:
- To investigate the potential of large-scale experimental studies, termed "mega-experiments," for identifying and assessing diffuse carcinogenic risks.
- To demonstrate the feasibility and effectiveness of mega-experiments in cancer research.
- To provide a framework for future research on low-potency carcinogens.
Main Methods:
- Designing and conducting "mega-experiments" involving a large number of animals.
- Extending exposure periods and biophase observation times to maximize detection of effects.
- Utilizing well-characterized animal models and standardized methodologies for consistency and sensitivity.
- Carefully observing and documenting all effects during the experimental period.
Main Results:
- Initial results from five mega-experiments conducted by the Ramazzini Foundation indicate the significant potential of this approach.
- The methods employed have shown promise in identifying and assessing diffuse carcinogenic risks.
- The data suggests that mega-experiments can yield reliable and sensitive results for low-potency carcinogens.
Conclusions:
- Mega-experiments represent a powerful and sensitive methodology for assessing diffuse carcinogenic risks.
- This approach can aid in reducing cancer incidence and mortality by identifying and controlling widespread environmental hazards.
- Further implementation of mega-experiments is recommended for comprehensive cancer risk assessment.
Related Concept Videos
Mutagenicity and Carcinogenicity
Toxicity Testing in Animals

![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)